So in this video, we are going to be talking about the top seven penny stocks that will be spiking in December 2019. But I Say this confidently not because I am a magical garden gnome, but rather because the companies on this list literally tell you the exact date, yet sometimes the exact time at which price acting, changing events are going to be occurring. They do this through letting us know the dates of their FDA approvals, their phase for all data releases, and their presentations, as well as dropping us many hints and clues. However, contrary to popular opinion, it is always important to do your own due diligence.

Unfortunately, it seems that a lot of folks like to just gamble on FDA approval plays and then they're like hey, maybe if I just pray to the stock market Buddha then it's going to get an approval and then I'll make money. Are you kidding me folks? The stock market doesn't care about your Buddha The purpose of these videos is always just to get you started and to motivate you to do your own work. If you think that listening to a random stock youtuber what the big Ekkada behind him is going to make you rich, you've got another thing coming. In fact, every few days I'll get a comment from someone that's like Charlie.

You dwarf your picks always come up short, but while I am a tall individual, my picks definitely come up short when it comes to long term investing. But why why Charlie is that? Well, because this is a trading channel, that means that we're trading fluctuations. We're not looking at things from long term perspectives. For example, a DNP was an FDA approval taker where literally everything went wrong.

The approval itself got delayed massively, but it provided three huge opportunities nonetheless, and you'll notice not one. Not one of these opportunities held long term. The first opportunity was the run up after breaking into an upward direction, the second was the massive run up on this particular day, allowing you to buy in a confirmation and sell out a validation, and the third was the overreaction correction from this beatdown. But if you had taken a position when I originally announced it right here, you would be at a loss.

The point is that if you're planning on taking a long term position and these penny stocks are going to have a bad time, do your own due diligence, have a trading plan, and focus on the fluctuations. But anyways, you know that a lot of work goes into making these videos and the only thing that I ask. The only thing that I ask of you in return is that you hit that ravishing like one. Okay and quick plug for the broke curious amongst you if you were wondering what broker to trade these stocks on.

I Always send new folks over to Weeble. Now they are in my opinion, one of the best brokers to get you started. Tons and tons of really cool scanning features such as After Hours Gainers Insider Activity Earnings calendars, and many other useful tricks and tools to get you earning income in the market. And of course, if you do sign up with our link below, you will get not one but two free stocks just for signing up and trying out an excellent broker.

Okay, so I want to start this month with an FDA approval That literally just happened a Qst now I Mentioned this in last month's video because they had publicly announced that they would be having an FDA approval by the end of November and that's what happened. I Announced it here and then we have this pre anticipatory run up and then eventual approval. but we never really know if there's going to be an approval or not. Remember there's an 80% chance of something getting approved based on the statistics, but you never know they can get delayed.

They can get disapproved. There can be other issues where they just don't announce the key is always in the price action. Now we love pre anticipatory run ups and that's what we had. Pre anticipatory run ups are sort of a double-edged sword.

They do give us an idea where the masses they can approval is headed because if the masses are bullish, they're going to buy into the position and anticipation before the announcement actually occurs. This gives us an idea of where the sentiment is for a particular stock, but pre anticipatory run ups also pre factor in approval. That means that when or if it actually gets approved, it's not going to run as much because it's already gone up a decent amount with people already factoring that into the share price and in the situation. We had a massive approval, but it's already been up over a hundred percent since the anticipatory run-up started.

People were anticipating an approval, so when it actually happened, we only saw a seven percent increase and to me this still looks overextended. But honestly, one of the things that you need to come to terms with as a trader is that we can't predict exactly when we've hit a top or are headed for a reversal. I Understand that sometimes when you're in a trade, it's really easy to feel like the price action is talking to you. It's like Charlie we're going to keep going or Charlie this is the top.

It's really easy to talk yourself into any sort of story when it comes to looking at the price, action, and being in a position, but the truth is every minute that you're not using a trading plan to execute is a minute that you're gambling. We do know that executing into a position with more elevating factors than deprecating factors is a high probability move that will push us forward in the long run. And right now, from a long-term perspective, we are overbought and have way more downward potential as compared to upward potential since this is a prior cattle display, we need to see an actual push back and then signs of price break that order to convince me to take a position. Remember, as traders, it's very important to trade like spoiled brats.

A lot of people get bored and they're like, oh, why don't I put money into a position that is a losing strategy. You need to trade like a spoiled brat and since this is a prior catalyst play, we need to see an actual push back and then signs of price ranked in order for me to be convinced to take a position. The interesting thing with a Qst is that our monkeys are still giving it an average price target at $24.50 which is of course, a whopping 212 percent of upside, which is interesting. Again, we don't trade based on analyst opinions of course, but this is an elevating factor because it means that more sheep investors are going to be bullish towards that level of upside.

Okay, next now 80 Nm will have their phase 3 data release. December 7th. The reason this makes me cringe is generally because I like to trade penny stocks that are have a little bit of a higher value. To me.

Once it gets below 50 cents or even a dollar, that's sort of just a race to the bottom. I Know that people think that a penny stock has to be under a dollar to be considered a penny stock, but the IRS designates it is under $5 I've decided to include a TNM in this list because of several reasons. At this particular point on October 24th, 80 Nm announced that they would be presenting their results from the first half of their phase 3 trial. They would be doing this on October 28th.

Essentially how FDA approval plays work is that they go through several phases, submissions and then an eventual FDA approval. This is a slow burn where each step of the way gets you closer to the end goal which is the FDA approval which could cause massive fluctuations in the price. but every step along the way also causes massive fluctuations because people are anticipating the results. So this announcement hither brought up investor interest.

It ran up in anticipation and then boom they announced the results. and since every reaction in the stock market is an overreaction, the price action went back down. But what we have just declared in effect is a history of price. Reacting to news events in regards to phase data releases and presentations, we have another FDA approval event coming up and what is it that we are seeing? We are seeing an anticipatory run-up.

We talked about this in depth and zipped rater you, but there are several different signs of a positive phase data release or positive fluctuation and a anticipatory run-up is one of those elevating factors. We also have our analyst / monkeys giving us an average price target at 275, but again, this is why we call them monkeys instead of distinguished ladies and gentlemen. So what is it that I am looking for? Well, more opportunities in the pre run-up and an opportunity on the day of where we can ride price drinks. Maybe this happens a few days before, maybe it gets delayed and we have opportunities after, but it really doesn't matter.

By the way, if you are not in a good trading group and you're having a hard time following these picks and finding opportunities as they present themselves, I Recommend that you immediately get into a good trading group. We of course have our free zip trader circle Facebook group which I'll link to in the description below, but this is a completely free group where we post nightly watchlist and you can interact and network with tons of other traders. Ok now a Vdl will be having their FDA approval on December 15th for their Hospital product. Now this got delayed by three months, but we love it when FDA approvals get delayed because that means that we can see the sentiment in the months leading up to it.

This gives us a peek into what these sheep are thinking, but moreover gives us the opportunity to look for previous signs of spike ability. Here we have a massive spike. This was September 23rd and quick research reveals that this was a spike on phase data news from that time period. Essentially, the FDA made a decision at that point that led to the acceleration of their phase data.

So we'll call this a phase data spike. That's all we need to know to declare spike ability. We just need to know that this is a stock that has previous history of spiking on FDA announcements. It does not mean that it will again, but we can be fairly confident that it is an elevating factor since this was a spike on a phase data announcement.

and we have an upcoming FDA approval announcement which is the mother of all announcements. Okay, but looking into the price action hither, we are in a long-term upward direction over our red directional SMA line. We have periods of price right over our blue price break. That's the main line, but we are trading a bit high.

So what I'm going to be looking for it leading up to this announcement date is either a pushing forward of price breaks or a pulling back hyper for pulling back because at the end of the day that would mean if we get an approval, we'd have more upward potential as it wouldn't have factored in the increase beforehand. Remember pre anticipatory run ups or double-edged swords if they pre factor it in? Sure that's an elevating factor, but again, it eats away at our upside. But the key either way is making sure that we're buying into price tranqs days where we have a huge increase in volume will indicate early reaction to news, but will also allow us to trade the price. Action: A lot of people mistakenly assume that I recommend folks buy into low flow low volume penny stocks, but I've never recommended that and I would never do that.

Personally, how do you trade a chart like this? He is waiting until we have higher volume. When you have hired all your going to have a healthier looking chart and what makes higher volume well, of course a catalyst so you could see how this all connects. But moreover, I should mention that a lot of folks mistakenly obsess about a drug getting approval. But the truth is that the only reason that you would be worried about whether or not a stock gets its FDA approval or not is if you randomly bought in without a plan in hopes that it would magically get approved.

Okay now a Mrn is going to have their FDA approval decision on December 28th for their drug for high triglycerides. Was there a list their high triglycerides? Every now and then someone's like Charlie you list be bastard and then I'm like what's flip Now this is a little bit of a stretch to call a penny stock, but this is a buy the books opportunity when it comes to biotech place. so we're going to go ahead and include it in the list. It had established spiked ability with the spike on November 12th correlating with its positive FDA news for the same drug in their pipeline that is coming up in December.

But when playing a movement like A.m. or N, remember, we wait for confirmation when we have strong elevating factors and then we sell out at validation. For example, with this opportunity here at Market Open, we had a fake-out confirmation, but then a solid confirmation that closed where we had increasing volume, a fair deal on the RSI, and a clear catalyst. These are some of our elevating factors.

Remember, we're always stacking or elevating factors to increase our odds of success overall. and that means that we can write the price drinks up and sell out at validation. Now with that being said, I Always get messages from folks that are like Charlie waiting for confirmation and selling out at validation. That's garbage.

Totally trashed. That means that you're going to be giving up some of your upside. However, it is so important to have a clear, a clear entry, and an exit point. because the truth is, folks that we as traders, we have no ability to tell exactly when we've reached the top or when we've reached the bottom.

So the key is to take a chunk of the move and to do that in a consistent way. And in my opinion, confirmation and validation is one of the strongest ways to do that. You're welcome to try something different. Maybe you could find something better, but for me this is my style and this is what I see Valuing folks.

Always have a clear plan and always execute on that clear plan. Now Cores will be having their FDA approval decision on December 24th for their drug for Atrial Fibrillation or Afib. This play is a little bit different. Core of is actually a company making a drug that has a huge market worldwide.

In fact, it established its spike ability here after news came out that Korres drug would be in more than 40 countries. now. We were just waiting for it to get approved in the United States. But why is this a big deal? Well, the Afib market in the US is Huge and it's expected to increase to Thirteen Point five, Eight nine, some billion by 2025.

Investors love drugs that fit future demand and this drug not only has future demand, but a huge amount of current demand entering one of the biggest markets. The United States is thus going to be huge for them. But Charlie how does this translate into trading? Well, we broke into an upper direction here over our Red, Directionless and Mayline and are now in a period of testing it. So what I'm looking for are two things I Want to see either a pre anticipation run-up or some strong signs of price strength right before the announcement on the 10th.

We also have a Advisory Committee meeting which could serve to bring in more investor acknowledgement and thus more volume into this play. Remember when we have upward sentiment, volume tends to push a stock up, but the key is using the increase in volume to gage sentiments and then base your decision on the other elevating factors that which are at your disposal. Okay, so next ITC I will be having their FDA approval on December 27th for their drug for Schizophrenia. Maybe I'm just hearing voices but it did declare spike ability previously here and here when it got beat down rapidly upon negative FDA announcements.

most notably when the FDA cancelled their panel review of one of their drugs. So, we've established reactiveness and spiked ability to. FDA Announcements: A lot of people think that it has to spike upwards in order to be considered a spike, but technically a spike is in either direction and likewise, we're just really looking for reactivity. Thus, simply finding spike ability is key here.

Sometimes folks are like hey Charlie, finding spike ability is really a waste of time. Of course, it's going to react to a big news announcement, but that's not always the case. Certain news announcements are going to get more press than others, and first, some types of stocks. they're not going to react if they have a big FDA play.

So make sure to establish previous spike ability. the STM will be having their phase 2 presentation on December 7th. The fun part of ESPN is that we have seen some serious spike ability and as of recently as of a couple weeks ago or as of the 22nd we saw a decent amount of Prai strength. We saw a huge ignition of confirmation conformational Prai strength to there and all of a sudden we had this pretty consistent running up and I do think that this is worth watching.

Another thing that I would be concerned about is making sure to follow the volume. Do we have a decent amount of volume? Where is the volume taking us Anyways folks, I Do hope that this video is useful for you. If you have any questions whatsoever, feel free to reach out to us below or join our free Zip Praetor Circle Facebook group. Also, if you do enjoy these top penny stock videos and see value in them, make sure to let us know in the comment section below.

I've also just started posting on Twitter so make sure to follow me at Zip Charlie if you are interested in the Twitter world. If you'd like to find these biotech plays yourself, all you have to do is go over to Bio Forma Catalyst Com. You could use their free features to find all of the different opportunities. Full disclosure: I'm not affiliated with them at all, but I've been using them for quite some time and they do a good job.

And of course if you'd like help growing your account and would like to do so in a structured environment at which I work with every single day. I Do recommend going ahead and checking out Zip Trader you. This is our premium course and I'll put the link to that in the description below. Anyways, have a great day and I'll see you in the next video.